Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Sleep Wake Disorders 1Pleural Diseases 1Mesothelioma, Malignant 1Hematologic Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 6Platinum 5Pemetrexed 51,2-diaminocyclohexaneplatinum II citrate 5pembrolizumab 4atezolizumab 2Radiotherapy 2Radiation 2Nivolumab 2Ipilimumab 2Gemcitabine 2Cyclophosphamide 2Carboplatin 2tremelimumab 1methoxyamine 1fludarabine 1decitabine and cedazuridine drug combination 1cediranib 1anetumab ravtansine 1aldesleukin 1Trioxsalen 1Tissue Banks 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Phototherapy 1Photochemotherapy 1Pharmacogenomic Testing 1Pharmaceutical Preparations 1Interleukin-2 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Phototherapy × 90 days × Clear all
NCT03678350 2026-03-27

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Roswell Park Cancer Institute

Phase 1 Completed
9 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Pleural Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡